Literature DB >> 19361478

Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.

J B Watson1, A Hatami, H David, E Masliah, K Roberts, C E Evans, M S Levine.   

Abstract

Most forms of Parkinson's disease (PD) are sporadic in nature, but some have genetic causes as first described for the alpha-synuclein gene. The alpha-synuclein protein also accumulates as insoluble aggregates in Lewy bodies in sporadic PD as well as in most inherited forms of PD. The focus of the present study is the modulation of synaptic plasticity in the corticostriatal pathway of transgenic (Tg) mice that overexpress the human alpha-synuclein protein throughout the brain (ASOTg). Paired-pulse facilitation was detected in vitro by activation of corticostriatal afferents in ASOTg mice, consistent with a presynaptic effect of elevated human alpha-synuclein. However basal synaptic transmission was unchanged in ASOTg, suggesting that human alpha-synuclein could impact paired-pulse facilitation via a presynaptic mechanism not directly related to the probability of neurotransmitter release. Mice lacking alpha-synuclein or those expressing normal and A53T human alpha-synuclein in tyrosine hydroxylase-containing neurons showed, instead, paired-pulse depression. High-frequency stimulation induced a presynaptic form of long-term depression solely in ASOTg striatum. A presynaptic, N-methyl-d-aspartate receptor-independent form of chemical long-term potentiation induced by forskolin (FSK) was enhanced in ASOTg striatum, while FSK-induced cAMP levels were reduced in ASOTg synaptoneurosome fractions. Overall the results suggest that elevated human alpha-synuclein alters presynaptic plasticity in the corticostriatal pathway, possibly reflecting a reduction in glutamate at corticostriatal synapses by modulation of adenylyl cyclase signaling pathways. ASOTg mice may recapitulate an early stage in PD during which overexpressed alpha-synuclein dampens corticostriatal synaptic transmission and reduces movement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361478      PMCID: PMC2670358          DOI: 10.1016/j.neuroscience.2009.01.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  82 in total

Review 1.  Neurotransmitter release at central synapses.

Authors:  Charles F Stevens
Journal:  Neuron       Date:  2003-10-09       Impact factor: 17.173

2.  Comparison of two forms of long-term potentiation in single hippocampal neurons.

Authors:  R A Zalutsky; R A Nicoll
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

3.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

4.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane.

Authors:  L Maroteaux; R H Scheller
Journal:  Brain Res Mol Brain Res       Date:  1991-10

5.  Isolation and characterization of synaptoneurosomes from single rat hippocampal slices.

Authors:  M W Johnson; J K Chotiner; J B Watson
Journal:  J Neurosci Methods       Date:  1997-12-01       Impact factor: 2.390

Review 6.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

7.  Regional differences in the expression of corticostriatal synaptic plasticity.

Authors:  R Smith; W Musleh; G Akopian; G Buckwalter; J P Walsh
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms.

Authors:  J H Wang; P T Kelly
Journal:  J Neurophysiol       Date:  1997-11       Impact factor: 2.714

9.  Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP.

Authors:  M G Weisskopf; P E Castillo; R A Zalutsky; R A Nicoll
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

10.  Short- and long-term synaptic depression in rat neostriatum.

Authors:  D M Lovinger; E C Tyler; A Merritt
Journal:  J Neurophysiol       Date:  1993-11       Impact factor: 2.714

View more
  42 in total

1.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

Review 2.  Folding and misfolding of alpha-synuclein on membranes.

Authors:  Igor Dikiy; David Eliezer
Journal:  Biochim Biophys Acta       Date:  2011-09-16

Review 3.  RNA-Seq and human complex diseases: recent accomplishments and future perspectives.

Authors:  Valerio Costa; Marianna Aprile; Roberta Esposito; Alfredo Ciccodicola
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

4.  Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.

Authors:  Timothy J Collier; Kinshuk R Srivastava; Craig Justman; Tom Grammatopoulous; Birgit Hutter-Paier; Manuela Prokesch; Daniel Havas; Jean-Christophe Rochet; Fang Liu; Kevin Jock; Patrícia de Oliveira; Georgia L Stirtz; Ulf Dettmer; Caryl E Sortwell; Mel B Feany; Peter Lansbury; Lisa Lapidus; Katrina L Paumier
Journal:  Neurobiol Dis       Date:  2017-07-12       Impact factor: 5.996

5.  Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.

Authors:  Sudhakar R Subramaniam; Iddo Magen; Nicholas Bove; Chunni Zhu; Vincent Lemesre; Garima Dutta; Chris Jean Elias; Henry A Lester; Marie-Francoise Chesselet
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

6.  Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.

Authors:  Theodore A Sarafian; Amneh Yacoub; Anastasia Kunz; Burkan Aranki; Grigor Serobyan; Whitaker Cohn; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2019-08-16       Impact factor: 4.164

7.  Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.

Authors:  Nanping Wu; Prasad R Joshi; Carlos Cepeda; Eliezer Masliah; Michael S Levine
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

Review 8.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 9.  Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Authors:  Carlos Cepeda; Damian M Cummings; Véronique M André; Sandra M Holley; Michael S Levine
Journal:  ASN Neuro       Date:  2010-04-07       Impact factor: 4.146

10.  Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines.

Authors:  Carlos Cepeda; Damian M Cummings; Miriam A Hickey; Max Kleiman-Weiner; Jane Y Chen; Joseph B Watson; Michael S Levine
Journal:  PLoS Curr       Date:  2010-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.